You're not going to squeeze a lifetime worth of lost salary out of a random Redditor who told you how to tweak your insulin pump.
Because the risk is worthwhile at times.
The exceptions typically apply to rare diseases that impact a population too small to be profitable enough to justify the $1B or more it may cost to shepherd a device or medication through the normal process.
These are populations who would be potentially unserved otherwise. (I'm of the personal opinion that this is where the government should step in instead of private industry, but I'm pretty left of center.)
https://www.fda.gov/industry/developing-products-rare-diseas...
IIRC, an exception of this sort was used to expedite an Ebola vaccine due to the recent outbreak... because, well, Ebola.